Home
Scholarly Works
Comparing inhibitor development in (plasma derived...
Conference

Comparing inhibitor development in (plasma derived vs. recombinant) FVIII/FIX concentrates in severe haemophilia: Reporting on 1392 PUPs from EUHASS and canadian registries

Authors

Fischer K; Lassila R; Peyvandi F; Gatt A; Hollingworth R; Lambert T; Kaczmarek R; Bettle A; Samji N; Rivard G

Volume

30

Pagination

pp. 100-100

Publisher

WILEY

Publication Date

February 1, 2024

Conference proceedings

HAEMOPHILIA

ISSN

1351-8216

Labels

Fields of Research (FoR)

Contact the Experts team